Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

68Ga-PSMA-11 PET in Patients With Prostate Cancer

NCT04777071 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT04777071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04777071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
68Ga-PSMA-11 PET in Patients With Prostate Cancer
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 17, 2021
Completion date
July 15, 2030
Enrollment
141 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biochemically recurrent prostate carcinoma, metastatic castration-resistant prostate carcinoma, prostate adenocarcinoma, stage iic prostate cancer ajcc v8, stage iii prostate cancer ajcc v8, stage ivb prostate cancer ajcc v8